In The News

Buyer Consortium Completes Privatization of ShangPharma

Practices: Private Equity

Ropes & Gray represented the buyer group consortium of TPG Growth and ShangPharma’s CEO, Michael Xin Hui, ShangPharma’s going private transaction, which closed March 27.

ShangPharma is a leading, China-based contract research organization.

The transaction is just the second private equity sponsor-backed going-private transaction of a China-based, NYSE or NASDAQ listed company to sign and close since the beginning of 2012.
Cookie Settings